St. Luke's Boise Medical Center Recognized as GammaTile® Center of Excellence
News related to:GT Medical Technologies · 2 min read
TEMPE, Ariz., Oct. 6, 2026 /CourierPR/ -- GT Medical Technologies has announced that St. Luke's Boise Medical Center has been designated as the latest GammaTile® Center of Excellence Program. This recognition underscores the hospital's leadership in patient care and its commitment to advancing brain tumor treatment through the GammaTile procedure.
The GammaTile® Center of Excellence Program is designed to identify and honor institutions and physicians who have demonstrated exceptional expertise in the GammaTile procedure. To achieve this designation, the participating physicians and their institutions must meet specific clinical criteria, maintain an annual case minimum, and adhere to ongoing education requirements.
The following physicians from St. Luke's Boise Medical Center have been recognized for their achievement:
- Edward A. Duckworth, MD, Cranial Surgery, Neurointerventional Surgery, Neurosurgery, Skull Base Surgery - David P. Bray, MD, Cranial Surgery, Neurosurgery - Derek L. Martinez, MD, Cranial Surgery, Neurosurgery - Benjamin G. McGahan, MD, Cranial Surgery, Neurosurgery - Cameron S. Thorpe, MD, Radiation Oncology - Tonya L. Kuhn, MD, Radiation Oncology - Stephen C. Smith, MD, Radiation Oncology - Timothy E. Sawyer, MD, Radiation Oncology - Amy Geyer, MS, Medical Physicist
GammaTile is an innovative form of radiation therapy that is placed at the time of tumor removal surgery. It delivers immediate, targeted radiation to the tumor site when cancer cells are at their lowest levels. Unlike conventional approaches, which often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment's effectiveness against remaining cancer cells and reduce the risk of regrowth.
The procedure has been adopted by more than 150 leading centers across the United States, underscoring its growing acceptance in both academic and community healthcare settings. According to data from J Neurooncol. 166:203-212 (2024), the GammaTile procedure is recognized for its role in improving the standard of care for patients with brain tumors.
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care.